Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125417591 | 12541759 | 1 | I | 2012 | 20160701 | 20160708 | 20160708 | EXP | BR-ABBVIE-16P-020-1671435-00 | ABBVIE | 82.33 | YR | F | Y | 53.90000 | KG | 20160708 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125417591 | 12541759 | 1 | PS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | UNKNOWN | 20725 | ||||||||||
| 125417591 | 12541759 | 2 | SS | RITMONORM | PROPAFENONE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | .5 | DF | Q12H | |||||||
| 125417591 | 12541759 | 3 | SS | RITMONORM | PROPAFENONE HYDROCHLORIDE | 1 | Oral | UNKNOWN | 0 | .5 | DF | Q12H | |||||||
| 125417591 | 12541759 | 4 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | Oral | DAILY DOSE: 40 MILLIGRAM; FASTING. | 0 | ||||||||||
| 125417591 | 12541759 | 5 | C | AAS | ASPIRIN | 1 | Oral | 0 | |||||||||||
| 125417591 | 12541759 | 6 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | |||||||||||
| 125417591 | 12541759 | 7 | C | CORUS | LOSARTAN POTASSIUM | 1 | Oral | DAILY DOSE: 50 MILLIGRAM; MORNING | 0 | 50 | MG | QD | |||||||
| 125417591 | 12541759 | 8 | C | CORUS | LOSARTAN POTASSIUM | 1 | Oral | 0 | |||||||||||
| 125417591 | 12541759 | 9 | C | CALCIUM | CALCIUM | 1 | Oral | DAILY DOSE: 1 TABLET; AT LUNCH | 0 | 1 | DF | QD | |||||||
| 125417591 | 12541759 | 10 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | |||||||||||
| 125417591 | 12541759 | 11 | C | WHEY PROTEIN | 2 | Oral | WHEY PROTEIN ISOLATE FROM MILK; DAILY DOSE: 1 MEASURE DOSE | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125417591 | 12541759 | 1 | Pancreatic disorder |
| 125417591 | 12541759 | 2 | Arrhythmia |
| 125417591 | 12541759 | 4 | Gastric disorder |
| 125417591 | 12541759 | 5 | Anticoagulant therapy |
| 125417591 | 12541759 | 6 | Blood cholesterol abnormal |
| 125417591 | 12541759 | 7 | Hypertension |
| 125417591 | 12541759 | 9 | Nutritional supplementation |
| 125417591 | 12541759 | 10 | Mineral supplementation |
| 125417591 | 12541759 | 11 | Nutritional supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125417591 | 12541759 | HO |
| 125417591 | 12541759 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125417591 | 12541759 | Abdominal pain | |
| 125417591 | 12541759 | Basal cell carcinoma | |
| 125417591 | 12541759 | Blood chromogranin A increased | |
| 125417591 | 12541759 | Blood gastrin increased | |
| 125417591 | 12541759 | Dehydration | |
| 125417591 | 12541759 | Diarrhoea | |
| 125417591 | 12541759 | Helicobacter infection | |
| 125417591 | 12541759 | Nasal cavity cancer | |
| 125417591 | 12541759 | Pancreatic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125417591 | 12541759 | 1 | 2012 | 0 | ||
| 125417591 | 12541759 | 2 | 2011 | 0 | ||
| 125417591 | 12541759 | 3 | 2014 | 0 | ||
| 125417591 | 12541759 | 4 | 2012 | 0 | ||
| 125417591 | 12541759 | 5 | 2006 | 0 | ||
| 125417591 | 12541759 | 6 | 2006 | 0 | ||
| 125417591 | 12541759 | 7 | 2006 | 0 | ||
| 125417591 | 12541759 | 9 | 2013 | 0 | ||
| 125417591 | 12541759 | 10 | 2012 | 0 |